Insmed

Insmed's 2025 annual report says that in early 2025 the company launched InQuiry, its proprietary generative AI assistant, which uses internal data to summarize documents, create content and produce meeting recaps. The report says InQuiry fully integrates across Insmed and is helping improve workflows, and that teams have realized productivity gains on tasks such as job descriptions, development plans and templates.

Insmed says it is leveraging AI for labor-intensive tasks that include determining next best actions for case managers on its Patient Services team, along with translating documents and producing HEOR dossiers. The same sentence says the company is exploring how AI may be used to write first drafts of IND applications and to assess business-development opportunities.

Insmed announced a collaboration with Google Cloud to use generative AI across drug discovery, drug development, drug commercialization and enabling functions. The release says the work runs on Google Cloud infrastructure and uses Google Cloud's AI technology, and that Insmed has built a generative AI search capability using Vertex AI Search trained on its internal documentation, plus separate indexed access to external medical publications.

Partners: Google Cloud

In the same release, Insmed says it is advancing an early-stage research engine that includes artificial intelligence-driven protein engineering, alongside gene therapy and protein manufacturing.